Solidion Technology STI Q4 2025 Earnings Negative EPS Highlights Development Stage Tempest Therapeutics Q1 2026 Earnings WiderthanExpected Loss Amid PreRevenue Development Stage SYM Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines GLIBK Q1 2026 Earnings EPS Misses Estimates Significantly Stock Rises 179 ATLCP Q1 2026 Earnings Preferred Stock EPS Surges Past Estimates with 2579 Beat ARCO Q1 2026 Earnings Strong EPS Beat Tempered by Market Skepticism BIOX Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Rises 231 SVV Q1 2026 Earnings Slight EPS Miss Fails to Dampen Investor Sentiment as Stock Gains 625 HL Q1 2026 Earnings EPS Misses Estimates by 101 Amid Operational Challenges